Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
08/25/2005 | CA2554559A1 Multiparticulate o-desmethylvenlafaxine salts and uses thereof |
08/25/2005 | CA2552638A1 Protease inhibitors for the treatment of digestive pathologies |
08/24/2005 | EP1566387A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof |
08/24/2005 | EP1566181A1 Novel medicament for ameliorating neurotransmission dysfunction diseases |
08/24/2005 | EP1565547A2 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
08/24/2005 | EP1565465A1 8-substituted imidazopyridines |
08/24/2005 | EP1565199A2 Therapeutic polypeptides,nucleic acids encoding same, and methods of use |
08/24/2005 | EP1565197A1 Papaya puree and the use of the same |
08/24/2005 | EP1565182A1 Treatment of gastrointestinal disorders with duloxetine |
08/24/2005 | EP1401841B1 Substituted 1-oxa-2,8-diaza-spiro 4,5]dec-2-ene derivatives as medicaments for the treatment of pain |
08/24/2005 | EP1392307B1 Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene |
08/24/2005 | EP1372624B1 Tramadol-based medicament |
08/24/2005 | EP1360185B1 Carboline derivatives |
08/24/2005 | EP1353927B1 Sulfamidothienopyrimidines and the use of the same as phosphodiesterase v inhibitors |
08/24/2005 | EP1353912B1 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof |
08/24/2005 | EP1335917B1 Condensed pyridoindole derivatives |
08/24/2005 | EP1272505B1 8beta-substituted-11beta-pentyl- and 11beta-hexyl-estra-1,3,5(10)-triene derivatives |
08/24/2005 | EP1216246B1 N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent |
08/24/2005 | EP1214304B1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes |
08/24/2005 | EP1169025B1 Transdermal drug delivery devices comprising a polyurethane drug reservoir |
08/24/2005 | EP1144394B1 1-heterocycle substituted diarylamines |
08/24/2005 | EP0914102B1 Compositions and methods for treating or preventing diseases of body passageways |
08/24/2005 | CN1659288A Method to inhibit cell growth using oligonucleotides |
08/24/2005 | CN1659183A Par-2-activating peptide derivative and pharmaceutical composition using the same |
08/24/2005 | CN1659170A Thienyl compounds |
08/24/2005 | CN1659169A Riboflavin derivative and its preparation method and uses |
08/24/2005 | CN1659164A Benzoxazinone-derived compounds, their preparation and use as medicaments |
08/24/2005 | CN1659163A Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis |
08/24/2005 | CN1659161A Piperidine derivatives having CCR3 antagonism |
08/24/2005 | CN1659157A Terphenyl derivatives, preparation thereof, compositions containing same |
08/24/2005 | CN1659151A 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
08/24/2005 | CN1659148A Aryloximes |
08/24/2005 | CN1659147A Pyridazine derivatives |
08/24/2005 | CN1659145A 3-cyanoquinolines as inhibitors of EGF-R and HER2 kinases |
08/24/2005 | CN1659144A Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
08/24/2005 | CN1659141A 1-sulfonyl-4-aminoalkoxy indole derivatives as 5-ht6-receptor modulators for the treatment of cns-disorders |
08/24/2005 | CN1658901A Methods for treating TWEAK-related conditions |
08/24/2005 | CN1658895A Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis |
08/24/2005 | CN1658889A Methods of treating ileus |
08/24/2005 | CN1658885A Hormone replacement therapy |
08/24/2005 | CN1658877A Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
08/24/2005 | CN1658876A A buffered, liquid nicotine composition for pulmonary administration |
08/24/2005 | CN1658875A 1-(4-piperidinyl) benzimidazolones as histamine H3 antagonists |
08/24/2005 | CN1658874A (1-4-piperidinyl) benzimidazole derivatives useful as histamine H3 antagonists |
08/24/2005 | CN1658866A Tri-substituted heteroaryls and methods of making and using the same |
08/24/2005 | CN1658865A Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin |
08/24/2005 | CN1658863A Severe sepsis preventive therapeutic agent |
08/24/2005 | CN1658862A Process for producing granules containing branched amino acids |
08/24/2005 | CN1658861A Novel formate salt of o-desmethyl-venlafaxine |
08/24/2005 | CN1658847A Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
08/24/2005 | CN1658844A Low dose liquid entecavir formulations and use |
08/24/2005 | CN1658840A Film-shaped mucoadhesive administration form for administering cannabis active ingredients |
08/24/2005 | CN1658828A Gallocatechin gallate-containing composition |
08/24/2005 | CN1658766A Process for producing lacturose-containing powder composition, lacturose-containing powder composition obtained by the process and feed additive |
08/24/2005 | CN1657534A Penthorum seponin (PCPTS) and its antihepatitis and antimutation aetion |
08/24/2005 | CN1657080A Oral liquid formula used for treating postparatum blood vacuity and its preparation method |
08/24/2005 | CN1657074A Chinese medicinal preparation for treatig stomatocace |
08/24/2005 | CN1657071A Asarum brain injection and its preparation method |
08/24/2005 | CN1657047A Formula of calebassine dripping pills and its preparation method |
08/24/2005 | CN1657043A Formula of lianbizhi preparation and its preparation method |
08/24/2005 | CN1216075C Hepatitis C virus high change region 1 synthetic peptide and its use |
08/24/2005 | CN1216056C Sulfamato hydroxamic acid metalloprotease inhibitor |
08/24/2005 | CN1215878C Composite hepatitis B vaccine for treatment and its preparation method |
08/24/2005 | CN1215873C Traditional Chinese medicine compound preparation for treating fatty liver and its preparation method |
08/24/2005 | CN1215866C Hepatosis treating medicine and its prepn process |
08/24/2005 | CN1215865C Traditional Chinese medicine for tonifying kidney |
08/24/2005 | CN1215860C Compsn. for health-care of teeth and curing oral disease and its preparation method and application |
08/24/2005 | CN1215849C Method for preparing baicalin liquid |
08/24/2005 | CN1215838C Declofenac sodium pastes and preparation thereof |
08/24/2005 | CN1215829C Medicinal toothpaste for treating oral disease |
08/24/2005 | CN1215828C Synergistic antiplaque/antigivitis oral composition |
08/24/2005 | CN1215801C Disease-proof health-care beverage and its producing process |
08/24/2005 | CN1215793C Health-care food with effects of regulating blood fat and improving intestinal tract function |
08/23/2005 | US6933387 Anti-obesity 1,2,3,4,10,10a-hexahydropyrazino[1,2-a]indoles |
08/23/2005 | US6933314 Integrin receptor inhibitors |
08/23/2005 | US6933313 Carbazoles with hydroxyfunctional amide (hydroxamic or esters) are for inhibiting sPLA2 mediated release of fatty acids for treatment of conditions such as septic shock |
08/23/2005 | US6933306 Anticancer agents; antiinflammatory agents; autoimmune disease |
08/23/2005 | US6932962 for use in pressurized metered dose inhalers (pMDI's); surfactants such as decyl glucoside or dodecyl maltoside |
08/23/2005 | CA2310585C Novel administration form comprising an acid-labile active compound |
08/23/2005 | CA2119006C Composition and method of treating hepatitis c |
08/23/2005 | CA2089442C Amino-substituted benzoylguanidines, process for their preparation, their use as a medicament and medicament containing them |
08/18/2005 | WO2005075641A1 Screening method |
08/18/2005 | WO2005075492A1 Prodrug comprising 5-aminosalicylate glycoside |
08/18/2005 | WO2005074976A1 Composition comprising polymeric material and uses thereof |
08/18/2005 | WO2005074957A1 Linseed extract for xerostomia treatment |
08/18/2005 | WO2005074954A1 Simarouba amara and/or momordica charantia extracts for the treatment of coccidiosis in poultry |
08/18/2005 | WO2005074952A1 Chinese medicine for treatment of irritable bowel sysndrome and the preparation thereof |
08/18/2005 | WO2005074923A1 Methods and compositions |
08/18/2005 | WO2005074911A1 Protein kinase c activator |
08/18/2005 | WO2005074909A1 Combination drug |
08/18/2005 | WO2005074908A1 Use of aminosalicylates in diarrhoea-predominent irritable bowel syndrome |
08/18/2005 | WO2005074907A1 Gene expression controlling agent |
08/18/2005 | WO2005074902A1 Rectal composition |
08/18/2005 | WO2003004608A3 Drug metabolizing enzymes |
08/18/2005 | US20050182246 An active site containing a hydrophobic surface of a binding pocket of amino acid residues Tyr-161, Phe-157, Arg-186, Leu-182, Arg-117, Phe-134, Leu-135, Leu-154, Phe-149, Ile-142, His-146, Arg-114, Lys-190, Ser-193, Ala-158, Tyr-138, Leu-115, Met-123, Phe-165, and Pro-118; improved gas binding property |
08/18/2005 | US20050182244 Modified polypeptides stabilized in a desired conformation and methods for producing same |
08/18/2005 | US20050182130 Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics |
08/18/2005 | US20050182103 Substituted 2,3-diphenyl pyridines |
08/18/2005 | US20050182101 Prodrugs of proton pump inhibitors |
08/18/2005 | US20050182099 Alkylammonium salts of omepazole and esomeprazole |